These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antipyrine disposition and liver size in the elderly. Swift CG, Homeida M, Halliwell M, Roberts CJ. Eur J Clin Pharmacol; 1978 Nov 16; 14(2):149-52. PubMed ID: 720377 [Abstract] [Full Text] [Related]
8. Antipyrin clearance in homozygous beta-thalassemia. Rifkind AB, Canale V, New MI. Clin Pharmacol Ther; 1976 Oct 16; 20(4):476-83. PubMed ID: 975719 [Abstract] [Full Text] [Related]
9. Effect of age on antipyrine metabolism in patients with gastric cancer. Higuchi T, Nakamura T, Uchino H. J Natl Cancer Inst; 1980 Nov 16; 65(5):897-900. PubMed ID: 6933259 [Abstract] [Full Text] [Related]
11. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits. Saitoh T, Kokue E, Shimoda M. J Vet Pharmacol Ther; 2000 Jun 16; 23(3):153-8. PubMed ID: 11110102 [Abstract] [Full Text] [Related]
13. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. Boxenbaum H. J Pharmacokinet Biopharm; 1980 Apr 16; 8(2):165-76. PubMed ID: 6107379 [Abstract] [Full Text] [Related]
14. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Vestal RE, Norris AH, Tobin JD, Cohen BH, Shock NW, Andres R. Clin Pharmacol Ther; 1975 Oct 16; 18(4):425-32. PubMed ID: 1164824 [Abstract] [Full Text] [Related]
15. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers. Posner J, Danhof M, Teunissen MW, Breimer DD, Whiteman PD. Br J Clin Pharmacol; 1987 Jul 16; 24(1):51-5. PubMed ID: 3620285 [Abstract] [Full Text] [Related]
16. Unaltered metabolism of phenytoin in thyroid disorders. Mølholm Hansen J, Skovsted L, Kampmann JP, Lumholtz BI, Siersbaek-Nielsen K. Acta Pharmacol Toxicol (Copenh); 1978 May 16; 42(5):343-6. PubMed ID: 581029 [Abstract] [Full Text] [Related]
17. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine. Shaw PN, Houston JB, Rowland M, Hopkins K, Thiercelin JF, Morselli PL. Br J Clin Pharmacol; 1985 Dec 16; 20(6):611-8. PubMed ID: 4091993 [Abstract] [Full Text] [Related]
18. Normal antipyrine metabolism in patients with cholesterol cholelithiasis. Evidence that the disease is not due to generalized hepatic microsomal dysfunction. Hepner GW, Vesell ES. Am J Dig Dis; 1975 Jan 16; 20(1):9-12. PubMed ID: 1115054 [Abstract] [Full Text] [Related]
19. The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Roberts CJ, Jackson L, Halliwell M, Branch RA. Br J Clin Pharmacol; 1976 Oct 16; 3(5):907-13. PubMed ID: 973986 [Abstract] [Full Text] [Related]
20. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. Teunissen MW, Spoelstra P, Koch CW, Weeda B, van Duyn W, Janssens AR, Breimer DD. Br J Clin Pharmacol; 1984 Nov 16; 18(5):707-15. PubMed ID: 6508980 [Abstract] [Full Text] [Related] Page: [Next] [New Search]